Integrative PANoptosis-focused omics analysis uncovers GSDMC as a candidate biomarker in breast cancer.

Front Cell Dev Biol · 2026 · PMC13311090 · PMID 42376459

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The risk score distribution showed an increasing trend from low to high risk ( Figure 3E ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.